April 18, 2019 - Registrations are now open for the 16th International Course on Dengue, Zika and Other Emergent Arboviruses to be held on August 12-23, 2019 at the Institute of Tropical Medicine “Pedro Kourí”, Havana, Cuba. Registration forms must ... Read more
March 27, 2019 - Scientists and technicians working on arbovirus projects in Brazil and across Latin America are meeting for a five-day training workshop organized by the Mérieux Foundation (ZikaPLAN) and Fundacao Faculdade de Medicina (ZIKAlliance) on March 25-29, 2019. Read more
March 6, 2019 - Resources include high-level justification for why engagement is important in an epidemic situation, as well as practical guides and tools on how to implement engagement activities in these circumstances. Read more
February 11, 2019 - The Birth Defect Surveillance Group, part of ZikaPLAN’s Work Package 8 (Disease Burden and Risk Assessment), announces the launch of the Global Birth Defects website. Read more
December 19, 2018 - Scientists at the KU Leuven Rega Institute, members of both the ZikaPLAN and ZIKAlliance consortia, have developed a new vaccine against the Zika virus. This vaccine should prevent the virus from causing microcephaly and other serious ... Read more
November 29, 2018 - Diagnosing Zika in the field presents specific challenges as other diseases, such as chikungunya and dengue, present in the same areas, can give a false positive on diagnostic tests. Read more
Enny S. Paixão et al. – PLOS ONE, March 28, 2019
In the article, the authors aimed to validate the linkage strategy they used in Paixao et al 2017 to create a cohort study on the effects of dengue on maternal and birth outcomes. The outcome of these series of studies will enable physicians to properly conduct a risk assessment in pregnant patients and policy-makers to use this information to include women with dengue in pregnancy in an “at risk” population.
Defining the spectrum of neurological diseases associated with Zika virus (ZIKV) infection, in both the central nervous system (CNS) and peripheral nervous system (PNS) of adults and children.
To protect pregnant women, novel, wash-in detergent formulations and long-lasting plastic technologies containing repellents for the treatment of clothing and other wearable repellent technologies are being developed using new microencapsulation techniques.
Identifying the major T-cell epitopes and cross reactive B-cell epitopes on ZIKV and assessing the role of flavivirus antibodies in protective and pathogenic immunity following ZIKV through antibody dependent enhancement (ADE).
ZikaPLAN has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 734584.